Chronic And Acute Kidney Disease

An analysis of online conversations among health care professionals on social media during September revealed mixed reactions toward newly updated messenger RNA COVID-19 vaccines.

Fewer than 40% of adults with diabetes received the clinically recommended testing for chronic kidney disease in 2017, according to a recently published study from the National Kidney Foundation and National Committee for Quality Assurance.

Compared with placebo, daprodustat was well tolerated and significantly increased hemoglobin levels in patients with chronic kidney disease, according to research presented at ASN Kidney Week.